申请人:Mirati Therapeutics, Inc.
公开号:US20170129857A1
公开(公告)日:2017-05-11
The present invention relates to compounds that inhibit LSD1 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.